Sign in

CIK 0001326110

  • Large accelerated filer

ImmunityBio, Inc.

Sign in to watch
Ticker
IBRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
431979754
Phone
+1 844-696-5235
Business address
3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
Former names
NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
  1. 4 Shares withheld for taxes Chief Financial Officer gave up 1,708 shares (to pay taxes)
  2. 4 Exercise or conversion Director acquired 277,725 shares (option exercise)
  3. 4 Exercise or conversion Director acquired 324,012 shares (option exercise)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Grant or award Director acquired 50,000 shares (grant or award)
  6. 4 Derivatives Options or other derivatives
  7. 4 Exercise or conversion Director acquired 15,429 shares (option exercise)
  8. 4 Exercise or conversion Director acquired 108,010 shares (option exercise)
  9. 4 Exercise or conversion Director acquired 100,000 shares (option exercise)
  10. 3/A Insider 3/A
  11. 4 Gift Director gave 16,000 shares (gift)
  12. 4 Gift Director gave 18,511 shares (gift)
  13. 5 Insider Annual Insider Trading Report
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy Chief Financial Officer bought 3,265 shares at an average $15.33 ($50,043)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market buy Chairman and CEO bought 450,000 shares at $23.00 ($10,350,000)
  19. 4 Open-market sale Director sold 450,000 shares at $23.00 ($10,350,000)
  20. 3 Insider Initial Statement of Ownership

Page 12 of 13 · 251 filings